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the injection may have triggered a 
reaction far more lethal than any future 
distant threat of a comparatively rare 
disease”.
The Health Editor of The Times, 
alongside sound advice under the 
headline “There are always risks, but 
this vaccine will save lives”, strongly 
implied that HPV vaccine had caused 
Natalie’s death. “Most experts agree 
that vaccinating against the virus 
that causes cervical cancer is a good 
thing,” he wrote. “It carries risks, 
as fatally shown in Coventry, but 
these are outweighed by benefits. 
Getting this across is far from easy.  
An unknown life saved decades 
down the line does not capture the 
imagination like the spectre on a 
young life lost.”
Equally surprising was an article in 
The Daily Telegraph (30 September) 
by a researcher at the Wellcome 
Trust Centre for the History of 
Medicine, London. “Politicians have 
long known that a life lost today is 
far more emotive than a life saved 
in some hard-to-glimpse future,” 
Mark Honigsbaum wrote. “Never 
mind that history is pitted with 
examples of vaccines that the public 
was falsely assured were safe: the 
experts reason that in every mass 
vaccination there are bound to be 
a few casualties.” Parents were 
entitled to weigh for themselves the 
risks of protecting their daughters 
by HPV vaccination, he said, “but 
there are also other methods, such 
as better screening”. The latter 
comment was particularly inept, 
since regular screening will continue 
for many years and is in no sense an 
alternative to immunisation.
In its article on 1 October, The 
Guardian pointed out that vaccination 
programmes had not been suspended 
(there had simply been a slight delay 
in certain areas receiving vaccine 
supplies), and that a “serious 
underlying medical condition” was 
probably responsible for Natalie 
Morton’s death. Next day, nearly 
all newspapers and radio and TV 
channels carried the pathologist’s 
finding of a “large malignant tumour 
of unknown origin in the heart and 
lungs”.
The immediate furore — though 
probably not underlying public  
anxiety — was at an end.
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American Association for  Microbiology.After considerable public and 
parliamentary debate in the UK that 
backed the creation of human–animal 
hybrid embryonic stem cells for 
research purposes, given the shortage 
of human-derived cells, research 
involving them currently appears to 
have been refused funding.
All three projects to develop 
embryonic stem cells from cloned 
embryos created by fusing human cells 
with animal cells have been stalled, 
after publicly-funded research councils 
refused to fund research involving 
the hybrid cells in this year’s grant 
applications.
Britain’s support for human–animal 
stem cell research seems to be 
faltering. Nigel Williams reports.
Stemmed cells Two of the projects failed to win funds earlier this year and the third 
is now understood to have ended 
when a funding application was 
withdrawn after the research licence 
issued by the Human Fertilisation 
and Embryology Authority (HFEA), 
responsible for such research, expired 
during the summer without being 
renewed, The Independent newspaper 
reported.
Plans to allow British scientists 
to create human–animal embryos 
were approved in 2007 by the HFEA 
after it published its lengthy public 
consultation document. It found that 
the majority of people were ‘at ease’ 
with scientists creating the hybrid 
embryos.
The new Human Fertilisation and 
Embryology Act, which came into force 
last month, was specifically amended 
to permit the creation of cloned Challenge: The UK’s support for embryonic stem cell research appears to be changing. 
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Honey bee populations in the US 
and in several European countries 
continue to suffer devastating 
losses, while the only firm scientific 
knowledge about the underlying 
causes so far is that they are 
multifactorial and include virus 
infections and environmental stress. 
The Co-operative Group, a group of 
companies in the UK that is owned by 
its membership and takes pride in its 
ethical conduct of business, has now 
started an awareness campaign which 
includes the launch of a documentary 
film and the propagation of a 10-point 
plan designed to enable everybody to 
take part in helping bee colonies to 
survive. 
The documentary Vanishing of 
the bees had its premiere at London 
and will be shown in independent 
cinemas across the UK during 
October and November (http://
vanishingbees.co.uk/screenings/). 
It highlights both the threat to crops 
depending on bee pollination and the 
need for more research to understand 
the causes of the problem. 
Martin Smith, the Chairman of 
the British Beekeepers Association 
(BBKA), said: “The film Vanishing of 
the bees calls for increased research 
into the possible sub-lethal effects 
of neonicotinoid pesticides on honey 
bees. In February this year, the BBKA 
called for work to be done on this 
area to try to establish if there is a 
link with the decline in bee numbers 
in the UK, when it published its 
Research Concept document.”
Neonicotinoid pesticides, such 
as clothianidin, affect the central 
nervous system of insects but are 
relatively harmless for mammals. 
They have been linked to a localised 
die-off of bees in Germany  
(Curr. Biol. 18, R684) and have been 
restricted in France, but they are still 
widely used in the UK. 
As part of its 10-point ‘Plan Bee’, 
the Co-operative Group, which 
is also the UK’s largest farmer, 
has pledged to stop the use of 
neonicotinoids on its own farms and 
in all own-brand fresh produce sold 
in its food stores.  It has also made a 
research grant of £150,000 available 
for studies into possible causes of 
the colony losses.
Other points included in Plan 
Bee aim at raising awareness and 
involving the company’s membership 
and customer base in grass-root 
measures to create a bee-friendly 
environment.
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The Co-operative Group of businesses 
in the UK has backed a film and a 
10-point plan to raise awareness of 
the continuing losses of vital bee 
colonies. Michael Gross reports. 
Bee screened
Chronic: The collapse in honey bee numbers is causing mounting concern. (Photo: Matthew 
Heinrichs/Alamy.)embryos with nuclei from human cells 
inserted into the eggs of either cows, 
pigs, sheep or other animals.
When the issue was debated in 
Parliament, many leading scientists 
strongly supported such research.
“Animal–human hybrid embryo 
research needs legal permission, good 
scientists and more funding,” says 
Evan Harris, the science spokesman 
for the Liberal Democrat Party. Many 
of those involved in campaigning for 
human–animal embryo research to 
be legal during the passage of the 
Human Fertilisation and Embryology 
Bill always knew that this was a 
controversial area of research. 
“But we also knew it was a field of 
enquiry which was necessary to keep 
open if those suffering from serious 
degenerative disorders were to be 
confident that all potential avenues 
for increasing knowledge about their 
condition, and indeed for funding 
possible treatments or even cures, 
were to be kept open,” he wrote in The 
Independent.
“It is disappointing — at least on 
one level — that a year after the bill 
became law, none of the three teams 
that had a licence granted to conduct 
hybrid embryo research has received 
funding from the research councils to 
do the work.”
But he believes the funding issue 
is not a boycott of the research. 
“The chief executive of the Medical 
Research Council has assured me that 
funding refusal of these applications 
was in no way a moral judgement on 
the work and was due solely to the 
imbalance between money available 
and the bids for it,” he says. But “the 
question remains, however, that if we 
are to save human eggs for fertility 
treatment, then we have to find 
efficient ways of using animal eggs 
(with their nuclear material removed) 
as a substitute for the use of precious 
human eggs when making cloned 
embryos for research purposes in the 
lab.”
While some researchers in the 
field are moving to other countries 
that are perceived to have a more 
favourable climate for embryonic stem 
cell research, Harris believes the UK 
will remain at the forefront. “Thanks 
to the HFE bill and the scientists who 
spent their time arguing their case to 
the politicians, the UK will remain a 
leading player in this work in the years 
to come, as long as the funding to 
bioscience is maintained.”
